SCHEMBL7339291

SCHEMBL7339291

CN1Cc2c(C(=O)O)ncn2-c2ccsc2C1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.72
CYP1A2 P05177 2/20 0.72
CYP2C19 P33261 2/20 0.72
CYP2C9 P11712 1/20 0.72
GABRA1 P14867 10/20 0.47
GABRG2 P18507 10/20 0.47
GABRB3 P28472 10/20 0.47
GABRA5 P31644 10/20 0.47
GABRA3 P34903 10/20 0.47
GABRA2 P47869 9/20 0.47
GABRA6 Q16445 9/20 0.47
GABRA4 P48169 3/20 0.47
GABRB2 P47870 3/20 0.43
MEN1 O00255 1/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRE P78334 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15024705 0.90 ALDH1A1 (0.72) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL8871074 0.89 ALDH1A1 (0.71) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL7278462 0.87 ALDH1A1 (0.78) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL8871218 0.86 ALDH1A1 (0.67) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL8871551 0.84 ALDH1A1 (0.74) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
Ro-194603 SCHEMBL2464268 0.84 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL7385731 0.84 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL7385733 0.84 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL7390814 0.82 ALDH1A1 (0.62) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1
SCHEMBL7370573 0.82 ALDH1A1 (0.62) ALDH1A1CYP1A2CYP2C19CYP2C9GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2575455-A2 METHODS AND COMPOSITIONS FOR TREATING A SUBJECT FOR CENTRAL NERVOUS SYSTEM (CNS) INJURY The Regents of the University of California (US) 2013-04-10 EP disclosed
WO-2011153377-A2 METHODS AND COMPOSITIONS FOR TREATING A SUBJECT FOR CENTRAL NERVOUS SYSTEM (CNS) INJURY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-12-08 WO disclosed
EP-0672666-B1 Imidazodiazepins HOFFMANN LA ROCHE (CH) 2001-07-25 EP disclosed
US-5665718-A ANXIOLYTIC, ANTICONVULSANT, MUSCLE RELAXANT, SEDATIVE, HYPNOTIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1997-09-09 US disclosed
EP-0790999-A1 OXAZOLYL- AND THIAZOLYLIMIDAZO-BENZO- AND THIENODIAZEPINES AND THEIR USE AS MEDICAMENTS F. HOFFMANN-LA ROCHE AG (CH) 1997-08-27 EP disclosed
WO-1996015129-A1 OXAZOLYL- AND THIAZOLYLIMIDAZO-BENZO- AND THIENODIAZEPINES AND THEIR USE AS MEDICAMENTS F. HOFFMANN-LA ROCHE AG (CH) 1996-05-23 WO disclosed
EP-0672666-A2 Imidazodiazepins F. Hoffmann-La Roche AG (CH) 1995-09-20 EP disclosed
EP-0150040-B1 Imidazodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-08-31 EP disclosed
US-4775671-A ANXIOLYTIC AGENTS, ANTICONVULSANTS, SEDATIVES, MUSCLE RELAXANTS HOFFMANN-LA ROCHE INC. (US) 1988-10-04 US disclosed
EP-0150040-A2 Imidazodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1985-07-31 EP disclosed